CT based radiomic approach on first line pembrolizumab in lung cancer
Abstract Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy. The aim of the study is to assess whether CT-derived texture parameters can predict overall survival (OS) and progression-free survival (PFS) in patients with advanced non-small-cell lung cancer (NSCLC)...
Enregistré dans:
Auteurs principaux: | Marta Zerunian, Damiano Caruso, Alberto Zucchelli, Michela Polici, Carlo Capalbo, Marco Filetti, Federica Mazzuca, Paolo Marchetti, Andrea Laghi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/18a7ae47de7d4a85ad1c5f7dd80511e2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer.
par: Qiao Liu, et autres
Publié: (2021) -
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer
par: Qiao Liu, et autres
Publié: (2021) -
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
par: Jie Zhang PhD, et autres
Publié: (2021) -
Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans
par: Hwan-ho Cho, et autres
Publié: (2021) -
Differentiating Central Lung Tumors from Atelectasis with Contrast-Enhanced CT-Based Radiomics Features
par: Rui Chai, et autres
Publié: (2021)